Literature DB >> 21790775

Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes.

O L Klein1, R Kalhan, M V Williams, M Tipping, J Lee, J Peng, L J Smith.   

Abstract

AIMS: In cohort studies, Type 2 diabetes mellitus has been associated with decreased forced 1 s expiratory volume and forced vital capacity. We examined if forced vital capacity, forced 1 s expiratory volume and diffusion lung capacity correlate with diabetes mellitus across different races in a clinical setting.
METHODS: We examined the medical records of 19,882 adults 18-97 years of age in our centre from 1 January 2000 to 1 May 2009. After excluding patients with diseases causing abnormal lung function, 4164 subjects were available for analysis. We used multiple linear regressions to examine cross-sectional differences in forced vital capacity, forced 1 s expiratory volume and carbon monoxide diffusing capacity between patients with and without diabetes mellitus, after adjustment for age, sex, race, height, smoking, BMI and heart failure.
RESULTS: Patients with diabetes (n = 560) were older (62 ± 12 vs. 55 ± 16 years), more likely to be men (56 vs. 43%), overweight (BMI 31.7 ± 8.5 vs. 27.3 ± 6.7 kg/m2 ), have heart failure (33 vs. 14%) and less likely to be Caucasians (65 vs. 76%) and never smokers (66 vs. 72%) compared with patients without diabetes (n = 3604). The mean unadjusted values in patients with diabetes vs. those without were: forced vital capacity 2.78 ± 0.91 vs. 3.19 ± 1.03 l; forced 1 s expiratory volume 2.17 ± 0.74 vs. 2.49 ± 0.0.83; and carbon monoxide diffusing capacity 16.67 ± 5.53 vs. 19.18 ± 6.72 ml(-1) min(-1) mmHg, all P < 0.0001. These differences remained significant after adjustment for covariates. After race stratification, only Caucasians with diabetes had a significant decrease in all lung function measures.
CONCLUSIONS: Patients with diabetes have decreased lung function compared with those without diabetes. Caucasians with diabetes have more global lung function impairment compared with African-Americans and Hispanics.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Year:  2012        PMID: 21790775     DOI: 10.1111/j.1464-5491.2011.03394.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Oana L Klein; Larissa Aviles-Santa; Jianwen Cai; Harold R Collard; Alka M Kanaya; Robert C Kaplan; Gregory L Kinney; Eliana Mendes; Lewis Smith; Gregory Talavera; Donghong Wu; Martha Daviglus
Journal:  Diabetes Care       Date:  2016-09-09       Impact factor: 19.112

2.  [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].

Authors:  Nikolaus Buchmann; Kristina Norman; Elisabeth Steinhagen-Thiessen; Ilja Demuth; Rahel Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-10-27       Impact factor: 1.281

3.  Association between glycemic state and pulmonary function and effect of walking as a protective factor in subjects with diabetes mellitus.

Authors:  Ji Min Kim; Min Kyeong Kim; Kyong Hye Joung; Ju Hee Lee; Hyun Jin Kim; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2019-10

4.  Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function.

Authors:  Yun-Yun He; Zhe Chen; Xiang-Yang Fang; Jing Chang; Yong Lu; Xiao-Juan Wang
Journal:  BMC Endocr Disord       Date:  2020-07-23       Impact factor: 2.763

Review 5.  Diabetic lung disease: fact or fiction?

Authors:  Saeed Kolahian; Veronika Leiss; Bernd Nürnberg
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 6.  Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis.

Authors:  Dongguang Wang; Yao Ma; Xiang Tong; Yonggang Zhang; Hong Fan
Journal:  Front Public Health       Date:  2020-06-03

7.  Pulmonary function tests in type 2 diabetes: a meta-analysis.

Authors:  Jesús Díez-Manglano; Uxua Asìn Samper
Journal:  ERJ Open Res       Date:  2021-02-01

8.  Functional independence and spirometry in adult post-intensive care unit patients.

Authors:  Lilian Regina Lengler Abentroth; Erica Fernanda Osaku; Mayara Manzoni Marques da Silva; Jaiane Luiza Jaskowiak; Renata de Souza Zaponi; Suely Mariko Ogasawara; Marcela Aparecida Leite; Cláudia Rejane Lima de Macedo Costa; Itamar Regazzo Pedreschi Porto; Amaury Cezar Jorge; Péricles Almeida Delfino Duarte
Journal:  Rev Bras Ter Intensiva       Date:  2021 Apr-Jun

Review 9.  Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.

Authors:  Thị Hằng Giang Phan; Panagiotis Paliogiannis; Gheyath K Nasrallah; Roberta Giordo; Ali Hussein Eid; Alessandro Giuseppe Fois; Angelo Zinellu; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

Review 10.  Idiopathic Pulmonary Comorbidities and Mechanisms.

Authors:  Maricica Pacurari; Amal Mitra; Timothy Turner
Journal:  Int J Inflam       Date:  2021-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.